These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6702587)

  • 21. [Strong lobbying for direct -to-consumer advertising of prescription drugs. Beneficial for the patient or for the increase of sales?].
    Hjemdahl P
    Lakartidningen; 2002 May; 99(21):2374-5. PubMed ID: 12090161
    [No Abstract]   [Full Text] [Related]  

  • 22. The price of seduction: direct-to-consumer advertising of prescription drugs in the US.
    Marks JH
    N C Med J; 2003; 64(6):292-5. PubMed ID: 14983622
    [No Abstract]   [Full Text] [Related]  

  • 23. ASHP's position on direct-to-consumer advertising of prescription drug products.
    Pierpaoli PG
    Am J Hosp Pharm; 1986 Jul; 43(7):1763-5. PubMed ID: 3752120
    [No Abstract]   [Full Text] [Related]  

  • 24. Consumer advertising of prescription drugs.
    Hayes AH
    Pa Med; 1983 Dec; 86(12):50-1. PubMed ID: 6689364
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA's drug abuse regulations.
    J Am Pharm Assoc; 1966 Jan; 6(1):11 passim. PubMed ID: 5901824
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 27. Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Rollins BL
    Int J Health Policy Manag; 2016 Feb; 5(4):287-8. PubMed ID: 27239875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advertising prescription-only drugs.
    Nightingale SL
    Lancet; 1998 May; 351(9115):1582. PubMed ID: 10326559
    [No Abstract]   [Full Text] [Related]  

  • 29. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 31. The great American medicine show revisited.
    Tomes N
    Bull Hist Med; 2005; 79(4):627-63. PubMed ID: 16327082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
    Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA
    Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 34. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
    Helmanis AM
    Food Drug Law J; 1996; 51(4):631-5. PubMed ID: 11797732
    [No Abstract]   [Full Text] [Related]  

  • 35. The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
    Kuhlik BN
    Food Drug Law J; 1995; 50(1):23-48. PubMed ID: 10342984
    [No Abstract]   [Full Text] [Related]  

  • 36. When ads trump evidence: is direct-to-consumer advertising leading practice?
    Nelson R
    Am J Nurs; 2007 Oct; 107(10):25-6. PubMed ID: 17895720
    [No Abstract]   [Full Text] [Related]  

  • 37. How should FDA regulate prescription drug promotion on the Internet?
    Opderbeck DW
    Food Drug Law J; 1998; 53(1):47-61. PubMed ID: 11795336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The new drug marketing: a consumer protection perspective.
    Woodward D
    Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct-to-consumer advertisements of prescription drugs.
    Council on Ethical and Judicial Affairs of the American Medical Association
    Food Drug Law J; 2000; 55(1):119-24. PubMed ID: 12322719
    [No Abstract]   [Full Text] [Related]  

  • 40. The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand. 'Possums in the headlights?'.
    Toop L; Richards D; Dowell T
    Br J Gen Pract; 2003 Apr; 53(489):342-5. PubMed ID: 12879848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.